esc
Search documents
go
Browse entities
go
Corpus stats
go
About the data
go
AI settings
go
EFTA
Search
Search
Entities
About
Stats
Settings
⌘K
search
Search
Search syntax help
Dataset
Set 1
Set 2
Set 3
Set 4
Set 5
Set 6
Set 7
Set 8
Set 9
Set 10
Set 11
Set 12
Sort
Relevance
Most pages
Most words
Dataset
Newest
Oldest
Status
All
Extracted
Failed
DOJ Status
All
Removed
Available
Modified
Date Range
Undated only
–
Email Headers
Page Count
–
Saved Searches
+
12 results for “
"EBV"
”
Export
Keyboard Shortcuts
/
Focus search
Esc
Blur input
O
Open PDF
←
→
Paginate
EFTA00506070
Dataset 9
2013-08-22
36p
3,940w
…Headquarters: San Francisco, CA 2 BcisL:er 2 EFTA00506071 2013-08-22 Epiphany Biosciences' Investment Thesis • Late-stage clinical antiviral company with two attractive, high-potential candidates • EP8-348 is a proven drug candidate with multiple "shots-on-goal" • Safe and effective small molecule with broad spectrum antiviral activity • fin competition for unmet medical needs • No antiviral approved for shingles associated pain • No approved antivirals for
EBV
• Paradigm-changing therapeutic approach to a variety of serious diseases, incl. orphan indications…
https://www.justice.gov/epstein/files/DataSet%209/EFTA00506070.pdf
EFTA02430465
Dataset 11
2010-01-31
1p
257w
Subject:
Some help
From:
-eggy mega
To:
jeevacation©gmail.com[jeevacation©gmail.com]
…anywhere to direct me or know someone w o cou • to p m p ease et me w . a you so muc for taking the time. Please feel free to forward this on to anyone you think might have some knowledge. The diagnosis ofMacrophage Activation Syndrome (MAS) is a relatively rare one (as a result of complications from either his Juvenile Rheumatoid Arthritis (JRA) and/or his Mono/
EBV
) there are few doctors, including the ones who are treating him…
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02430465.pdf
EFTA00614609
Dataset 9
2011-01-20
1p
379w
…In addition, two additional tests will be commercialized for use outside the United States for the determination of viral load for Epstein-Barr virus (
EBV
) and BK Virus (BKV). "We are extremely pleased to capture the synergies between IMDx and Abbott and to be able to offer these important tests to patients globally. The test areas under this agreement directly address a major unmet need in the clinical lab: high quality tests that are FDA cleared if for US sales…
https://www.justice.gov/epstein/files/DataSet%209/EFTA00614609.pdf
EFTA00640072
Dataset 9
2011-01-20
2p
505w
Subject:
IMDx Enters into Agreement with Abbott
From:
"Alice Jacobs"
To:
"Alice Jacobs"
…In addition, two additional tests will be commercialized for use outside the United States for the determination of viral load for Epstein-Barr virus (
EBV
) and BK Virus (BKV). "We are extremely pleased to capture the synergies between IMDx and Abbott and to be able to offer these important tests to patients globally. The test areas under this agreement directly address a major unmet need in the clinical lab: high quality tests that are FDA cleared if for US sales…
https://www.justice.gov/epstein/files/DataSet%209/EFTA00640072.pdf
EFTA00902109
Dataset 9
2011-01-21
3p
622w
Subject:
Re: IMDx Enters into Agreement with Abbott
From:
Jeffrey Epstein <
[email protected]
>
To:
Alice Jacobs
…In addition, two additional tests will be commercialized for use outside the United States for the determination of viral load for Epstein-Barr virus (
EBV
) and BK Virus (BKV). 'We are extremely pleased to capture the synergies between IMDx and Abbott and to be able to offer these important tests to patients globally. The test areas under this agreement directly address a major unmet need in the clinical lab: high quality tests that are FDA cleared if for US sales…
https://www.justice.gov/epstein/files/DataSet%209/EFTA00902109.pdf
EFTA00648481
Dataset 9
2011-01-21
2p
669w
Subject:
RE: IMDx Enters into Agreement with Abbott
From:
"Alice Jacobs" •
To:
"Jeffrey Epstein" <
[email protected]
>
…In addition, two additional tests will be commercialized for use outside the United States for the determination of viral load for Epstein-Barr virus (
EBV
) and BK Virus (BKV). "We are extremely pleased to capture the synergies between IMDx and Abbott and to be able to offer these important tests to patients globally. The test areas under this agreement directly address a major unmet need in the clinical lab: high quality tests that are FDA cleared if for US sales…
https://www.justice.gov/epstein/files/DataSet%209/EFTA00648481.pdf
EFTA00072524
Dataset 9
4p
437w
…- vt•tt2(4 0.4%•MV makt Mvierale d t ?Lto tautes viune • sod letrd EttAo svi-w-mkutr,coge5eiteti- al/t4inf -rr dit(SaMi- Mak
ebv
krt <G1h 'klit/Pk • Pinot` Y7' pe 0-W1/teem-of —"kt Pars 94~ - «wo cramy ~Ik e ~wi _ kvlet deern atoon 0,457k. covn+ "yeeA-1 er:500i Oatalt-r-slk Vtfr/vt %Lennie ik aVeWleti tk± - 0141 rentefluk coni 7g iltt 1149 415" #Wnl ielsVin goleA -- Petzvt ofecin ,afic,v Ris…
https://www.justice.gov/epstein/files/DataSet%209/EFTA00072524.pdf
EFTA00293426
Dataset 9
2014-02-27
16p
5,561w
…Geography (Listed Equities) & Macro (Equity Indices & Commodlites, G20 Gov. Credit) - APAC — EMEA — AMER Epu tyCorn — G20 Rates 0 se 0 0 „,0. e 1,c:),4) e 0 1.0 0
ebV
43C? A\ 4 41.1 4V 3 43V AV C3\ EFTA00293429 Atorus, LIC 2/27/2014 Current Gross Notional Risk by Category dor 243,884 ■ APAC ■ EMEA ■ AMER ■ EquityCom ■ G20 Rates Performance Vs. MSCI World Index Rolling 30 Day Realized Volatility - Ator EFTA00293430…
https://www.justice.gov/epstein/files/DataSet%209/EFTA00293426.pdf
EFTA00103635
Dataset 9
54p
5,635w
…TIME OF FOLLOW-UP CA ZeF 7/4/ /7 A 7J- 7 1/41 PERSON INTERVIEWED (Include DON, address and Phoneltk INTERVIEW NOTES: • Were they a — • How do they know him— h-
ebv
:9 4 VI ,Al () 1_119141-C 4-LiC • When did they meet him — 6,,/,v7y NlY) (-- • Where did they meet him — • How old were they when they met him (If pertains to the Victim)— • Additional Info- FOLLOW UP REQUIRED. e 610.0 fr,-a/7-7 …
https://www.justice.gov/epstein/files/DataSet%209/EFTA00103635.pdf
EFTA00807328
Dataset 9
2019-03-07
17p
4,330w
…while SoulCycle and Flywheel search trends have flattened out • We believe this demonstrates the significant lead Peloton has over competing brands Google Trends for Premium Cycling Brands 100 90 Consumers increasingly 80 searching for Peloton 70 60 50 40 30 20 10 0 ,*? " <7' 4' t (0 No.A
ebv
4) N. "‘ .y0 'Y0 4<bc >•>\. —Peloton SoulCycle —Flywheel Source: Google Trends (for searches in the U.S.) STRICTLY CONFIDENTIAL. NOT FOR DISTRIBUTION 9 EFTA00807337 INVESTMENT HIGHLIGHTS: BRAND RECOGNITION…
https://www.justice.gov/epstein/files/DataSet%209/EFTA00807328.pdf
EFTA00765781
Dataset 9
21p
6,612w
…commercially available test, yet this is nearly unanimous in placing high on the demand list by physicians and lab directors. The market for a Bordetella test is estimated to be between $50 and $100MM worldwide, with the availability of a cleared test expected to correct underreporting, which will drive more test growth as the relevance increases. IMDx Pan-QuantTM Immunocompromised Viral Monitoring Detects and quantifies viral load for Epstein Barr Virus (
EBV
), Cytomegalovirus (CMV), BK Virus, and adenovirus; all are…
https://www.justice.gov/epstein/files/DataSet%209/EFTA00765781.pdf
EFTA00730018
Dataset 9
21p
6,610w
…commercially available test, yet this is nearly unanimous in placing high on the demand list by physicians and lab directors. The market for a Bordetella test is estimated to be between $50 and $100MM worldwide, with the availability of a cleared test expected to correct underreporting, which will drive more test growth as the relevance increases. IMDx Pan-QuantTM Immunocompromised Viral Monitoring Detects and quantifies viral load for Epstein Barr Virus (
EBV
), Cytomegalovirus (CMV), BK Virus, and adenovirus; all are…
https://www.justice.gov/epstein/files/DataSet%209/EFTA00730018.pdf
Corpus: 1990-03-17 – 2025-12-01
←
August 2013
→
Mo
Tu
We
Th
Fr
Sa
Su
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Undated
(150,429)
None
Light
Medium
Heavy
Results by Dataset
12 total
Set 9
11
Set 11
1